Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.

Doctors address the pros and cons of Health Resources and Services Administration’s new guidance, including at-home ...

A study of more than 45,000 women found that screening women according to their level of risk was as effective in detecting tumors as the one-size-fits-most screening currently recommended. By Roni ...

Approximately 80 percent of patients who have the hepatitis C virus may have been missed through EMR-reliant risk-based testing, according to research from the CDC. The paper, published in Clinical ...

The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...

All adults should have their blood tested for hepatitis B — a vaccine-preventable virus that harms the liver — at least once in their life, regardless of their risk factors for the infection, ...

For stable, symptomatic patients with suspected CAD who are deemed to be at “minimal risk” using a CT-based tool, deferral of diagnostic testing is just as safe as the usual approach and is even ...

Clinicians who test for albuminuria provide better evidence-based care to their patients than those who do not, research finds. Screening for chronic kidney disease (CKD), particularly albuminuria, is ...